APA (7th ed.) Citation

OS, S., N, L., ZB, H., R, O., AR, B., HL, D., . . . L, Ø. (2010). Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: A randomized, controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 51(1), 42. https://doi.org/10.1086/653112

Chicago Style (17th ed.) Citation

OS, Søgaard, Lohse N, Harboe ZB, Offersen R, Bukh AR, Davis HL, Schønheyder HC, and Østergaard L. "Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV-infected Adults with a Toll-like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 51, no. 1 (2010): 42. https://doi.org/10.1086/653112.

MLA (9th ed.) Citation

OS, Søgaard, et al. "Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV-infected Adults with a Toll-like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 51, no. 1, 2010, p. 42, https://doi.org/10.1086/653112.